elezanumab

Ligand id: 9290

Name: elezanumab

Classification
Compound class Antibody
International Nonproprietary Names
INN number INN
10344 elezanumab
Synonyms
ABT-555
AE12-1Y-QL
Database Links
Specialist databases
IMGT/mAb-DB 650
Other databases
Search PubMed clinical trials elezanumab
Search PubMed titles elezanumab
Search PubMed titles/abstracts elezanumab
Comments
Elezanumab (ABT-555) is a fully human monoclonal antibody targeting repulsive guidance molecule-a (RGMA), in development as a potential therapy for multiple sclerosis (MS).
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. BLAST peptide anaylsis reveals identical matches with peptides claimed in patent WO2013112922 [2].